Authors : Jaya Rama Rao Ponnamanda

Volume/Issue : Volume 10 - 2025, Issue 4 - April

Google Scholar : https://tinyurl.com/4c3a7v7v

Scribd : https://tinyurl.com/bevpwyu6

DOI : https://doi.org/10.38124/ijisrt/25apr116

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Urinary retention (UR) is characterized by impaired bladder emptying and the presence of post-void residual urine. Certain medications, particularly those with anticholinergic or noradrenergic effects, can interfere with micturition pathways, leading to UR1, 2. This case report presents a 24-year-old male with recurrent drug-induced urinary retention caused by duloxetine and desvenlafaxine. The patient was first admitted in January 2023 with severe abdominal pain and low mood and diagnosed with Severe Bodily Distress Disorder. Treatment with duloxetine (40 mg) led to acute urinary retention within two days, requiring catheterization. Reducing duloxetine to 20 mg resolved the UR. After discontinuation and subsequent readmission in March 2023 with similar symptoms, initiation of desvenlafaxine (100 mg) again triggered urinary retention, necessitating catheterization. Uroflowmetry indicated a functional cause. Desvenlafaxine was cross tapered with sertraline, resulting in significant improvement without recurrence of UR. This case underscores the importance of careful medication selection and monitoring in patients susceptible to drug-induced urinary side effects.

Keywords : Urinary Retention; Antidepressants; Bodily Distress Disorder; Serotonin-Norepinephrine Reuptake Inhibitors.

References :

1. Viktrup L, Pangallo BA, Detke MJ, Zinner NR. Urinary side effects of duloxetine in the treatment of depression and stress urinary incontinence. Prim Care Companion J Clin Psychiatry. 2004;6(2):65–73. doi:10.4088/pcc.v06n0204. PMID: 15254599; PMCID: PMC427601..
2. ​Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373–88. doi: 10.2165/00002018-200831050-00002. PMID: 18422378.
3. Aydin MB, Erken Y, Gundogmus I, Tasdelen Kul A. Evaluation of urinary incontinence in women admitted to the gynecology outpatient clinic. Ann Med Res. 2019;26(10):2484–6. doi:10.5455/annalsmedres.2019.09.548.